Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation

被引:90
作者
Abad-Zapatero, Cele [1 ]
Perisic, Ognjen [1 ,2 ]
Wass, John [3 ]
Bento, A. Patricia [4 ]
Overington, John [4 ]
Al-Lazikani, Bissan [4 ,5 ]
Johnson, Michael E. [1 ]
机构
[1] Univ Illinois Chicago MC870, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA
[2] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-6900 Lugano, Switzerland
[3] Quantum Cat Consultants, Lake Forest, IL 60045 USA
[4] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England
[5] Inst Canc Res, Haddow Labs, Surrey, England
基金
英国惠康基金;
关键词
TYROSINE-PHOSPHATASE; 1B; MARKETED ORAL-DRUGS; SELECTIVE INHIBITOR; BINDING AFFINITIES; PDBBIND DATABASE; STRUCTURAL BASIS; DISCOVERY; DESIGN; CHEMISTRY; PTP1B;
D O I
10.1016/j.drudis.2010.08.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We propose a numerical framework that permits an effective atlas-like representation of chemico-biological space based on a series of Cartesian planes mapping the ligands with the corresponding targets connected by an affinity parameter (K(i) or related). The numerical framework is derived from the concept of ligand efficiency indices, which provide a natural coordinate system combining the potency toward the target (biological space) with the physicochemical properties of the ligand (chemical space). This framework facilitates navigation in the multidimensional drug discovery space using map-like representations based on pairs of combined variables related to the efficiency of the ligands per Dalton (molecular weight or number of non-hydrogen atoms) and per unit of polar surface area (or number of polar atoms).
引用
收藏
页码:804 / 811
页数:8
相关论文
共 41 条
  • [1] Ligand efficiency indices as guideposts for drug discovery
    Abad-Zapatero, C
    Metz, JT
    [J]. DRUG DISCOVERY TODAY, 2005, 10 (07) : 464 - 469
  • [2] Ligand efficiency indices for effective drug discovery
    Abad-Zapatero, Cele
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (04) : 469 - 488
  • [3] A Sorcerer's apprentice and the rule of five: from rule-of-thumb to commandment and beyond
    Abad-Zapatero, Cele
    [J]. DRUG DISCOVERY TODAY, 2007, 12 (23-24) : 995 - 997
  • [4] Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B
    Ala, Paul J.
    Gonneville, Lucie
    Hillman, Milton
    Becker-Pasha, Mary
    Yue, Eddy W.
    Douty, Brent
    Wayland, Brian
    Polam, Padmaja
    Crawley, Matthew L.
    McLaughlin, Erin
    Sparks, Richard B.
    Glass, Brian
    Takvorian, Amy
    Combs, Andrew P.
    Burn, Timothy C.
    Hollis, Gregory F.
    Wynn, Richard
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (49) : 38013 - 38021
  • [5] Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics
    Ala, Paul J.
    Gonneville, Lucie
    Hillman, Milton C.
    Becker-Pasha, Mary
    Wei, Min
    Reid, Brian G.
    Klabe, Ronald
    Yue, Eddy W.
    Wayland, Brian
    Douty, Brent
    Polam, Padmaja
    Wasserman, Zelda
    Bower, Michael
    Combs, Andrew P.
    Burn, Timothy C.
    Hollis, Gregory F.
    Wynn, Richard
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (43) : 32784 - 32795
  • [6] 2-(Oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases
    Andersen, HS
    Iversen, LF
    Jeppesen, CB
    Branner, S
    Norris, K
    Rasmussen, HB
    Moller, KB
    Moller, NPH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) : 7101 - 7108
  • [7] Structure-based dissection of the natural product cyclopentapeptide chitinase inhibitor argifin
    Andersen, Ole A.
    Nathubhai, Amit
    Dixon, Mark J.
    Eggleston, Ian M.
    van Aalten, Daan M. F.
    [J]. CHEMISTRY & BIOLOGY, 2008, 15 (03): : 295 - 301
  • [8] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [9] Science, art and drug discovery: a personal perspective
    Campbell, SF
    [J]. CLINICAL SCIENCE, 2000, 99 (04) : 255 - 260
  • [10] Chen X, 2001, BIOPOLYMERS, V61, P127, DOI 10.1002/1097-0282(2002)61:2<127::AID-BIP10076>3.0.CO